Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

IntroductionCAR T-cell therapy has emerged as a promising new immuno-oncology treatment that engages the patient’s immune system to fight certain hematological malignancies, including diffuse large B-cell lymphoma (DLBCL). In the European Union (EU), CAR T-cell therapies have been approved for relap...

Full description

Bibliographic Details
Main Authors: Miguel Á. Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, Barthold Deiters, Claudio Jommi, Reinhard Marks, Catherine Rioufol, Juan M. Sancho Cia, Armando Santoro, Eva M. Wagner-Drouet
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Medicine
Subjects:
CAR T-cell therapy
diffuse large B-cell lymphoma
patient access
health system
Germany
France
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1128295/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1128295/full

Similar Items